/ /

Michelle Dalton
Anti-factor D reduces GA progression 20%
Phase II clinical study results indicate monthly lampalizumab therapy may be successful treatment
Determining ocriplasmin success
A new agent aimed at treating symptomatic vitreomacular adhesion can affect patients differently depending on several components.
Application of iOCT to ophthalmic surgery: Pioneer 18-month results
PIONEER study results find that intraoperative optical coherence tomography is vital for vitreoretinal surgery and recovery.
Genetic testing shows promise in predicting AMD progression
New study results show using genetic testing and phenotypic evaluations together in patients with drusen can increase the likelihood of determining who may develop advanced AMD.


View Results